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Subunit 9 (dicyclohexylcarbodiimide binding protein, ‘proteolipid’) of the mitochondrial F lFo-ATPase is a 
nuclearly coded protein in Neurospora crassa. It is synthesized on free cytoplasmic ribosomes as a larger precursor 
with an NH2-terminal peptide extension. The peptide extension is cleaved off after transport of the protein into 
the mitochondria. A processing activity referred to as processing peptidase that cleaves the precursor to subunit 
9 and other mitochondrial proteins is described and characterized using a cell-free system. Precursor synthesized 
in vitro was incubated with extracts of mitochondria. Processing peptidase required Mn2 + for its activity. 
Localization studies suggested that it is a soluble component of the mitochondrial matrix. The precursor was 
cleaved in two sequential steps via an intermediate-sized polypeptide. The intermediate form in the processing of 
subunit 9 was also seen in vivo and upon import of the precursor into isolated mitochondria in vitro. The two 
cleavage sites in the precursor molecule were determined. The data indicate that: (a) the correct NH2-terminus 
of the mature protein was generated, (b) the NH2-terminal amino acid of the intermediate-sized polypeptide is 
isoleucine in position - 31. The cleavage sites show similarity of primary structure. It is concluded that processing 
peptidase removes the peptide extension from the precursor to subunit 9 (and probably other precursors) after 
translocation of these polypeptides (or the NH2-terminal part of these polypeptides) into the matrix space of 
mitochondria. 
The majority of mitochondrial proteins are encoded by 
nuclear genes [l]. They are synthesized on free cytoplasmic 
ribosomes as water-soluble species, i.e. precursor proteins [2]. 
In many cases these precursor forms carry NH,-terminal pep- 
tide extensions not present in the mature proteins [3]. The free 
precursors are then selectively transported to their functional 
sites within the mitochondria. Transport is accompanied by 
one or more processing steps which may include covalent 
modifications of precursor proteins and/or proteolytic re- 
moval of peptide extensions. The assembly of cytochromes c 
and c1 requires the covalent attachment of the heme group 
[4- 61. In a few cases proteolytic processing takes place in two 
steps, as has been shown for cytochrome c1 in Neurospora 
and yeast and for cytochrome b2 in yeast [5, 61. 
The mitochondrial enzymes involved in processing have 
not been extensively characterized. Proteolytic activities have 
been detected in extracts of mitochondria from different 
sources [7 - 91, which can remove the NH2-terminal peptide 
extensions or at least part of them from precursor proteins. 
A partial purification of this activity from yeast mitochondria 
has been achieved [ 101. The processing activities investigated 
so far have several features in common: they appear to be 
soluble components of the mitochondrial matrix and they 
require divalent metal ions such as Mn2’ or Zn2+ for full 
activity. The processing activity responsible for the second 
cleavage of cytochromes c1 and b2 is thought to reside on the 
outer face of the inner mitochondrial membrane [6]. This 
latter activity does not require divalent metal ions, but a 
submitochondrial processing assay has not yet been estab- 
lished. 
We have characterized the processing activity referred to as 
processing peptidase with cleaves the precursor to Neurospora 
ATPase subunit 9 (‘proteolipid’, dicyclohexylcarbodiimide 
binding protein, Su 9). The precursor (pre Su 9) has an M ,  of 
16400 whereas the mature protein has an M ,  of 10500 [ll]. 
We have used a cell-free translation system as a source for the 
precursor, and extracts from isolated Neurospora mito- 
chondria as a source of processing peptidase. The activity 
depends on the presence of divalent metal ions and can be 
inhibited by chelating agents. It appears to be located in the 
mitochondrial matrix and cleaves pre Su 9 in two steps via an 
intermediate-sized polypeptide. The two cleavage sites show 
striking similarities in their primary structure as deduced from 
radiosequencing experiments. The results presented suggest 
that the intermediate-sized polypeptide represents a true inter- 
mediate in the assembly pathway of Su 9. 
MATERIALS AND METHODS 
Growth of Neurospora and preparation of mitochondria 
Neurospora crassa wild-type 14A was grown and metaboli- 
cally labeled as described [I 21. Mitochondria were isolated 
after disrupting cells by grinding with sand according to 
published procedures [12]. The isolation medium was 0.25 M 
sucrose, 1 mM EDTA, 30 mM Tris/HCl, pH 7.5, 1 mM 
phenylmethylsulfonyl fluoride. 
Subfractionation of mitochondria 
For preparation of mitochondrial extracts, mitochondria 
were suspended at a concentration of 5 mg mitochondrial 
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protein/ml in 30 mM Tris/HCl, pW 8.2, 0.1 mM phenyl- 
methylsulfonyl fluoride. The suspension was sonicated 3 x 5 s 
at I-min intervals and centrifuged for 1 h at 166000 x g. The 
supernatant containing the processing activity was stored in 
aliquots at -20°C. 
For localization experiments, mitochondria were 
fractionated as follows : mitochondria were suspended at a 
concentration of 7 nig mitochondrial protein/ml in 0.25 M 
sucrose, 30 mM ‘lris/HCl, pH 7.5, 0.1 mM phenylmethylsul- 
fonyl fluoride (STP buffer) and incubated for 10 rnin at 0°C 
with 1.4 mg/ml lyophilized cytosolic proteinase inhibitor frac- 
tion (see below). 5 100 pl aliquots of this suspension were 
separately mixed with 100 p1 of a freshly prepared solution of 
digitonin (Merck, Darmstadt, FRG) (O-O.8% w/v in STP 
buffer, made up from the same stock), so that the final concen- 
trations were 0, 0.1, 0.2, 0.3, 0.4% of digitonin, respectively. 
After 1 min of incubation at 0 “C, the samples were diluted by 
adding 1.2 ml of STP buffer and layered on a sucrose cushion 
of 600 pl of 0.7 M sucrose, 30 mM Tris/HCl, pH 7.5. The 
samples were centrifuged for 10 min at 48000xg. The 
supernatants including the sucrose cushion (2 ml total) were 
removed and the pellets were resuspended in 200 p1 of STP 
buffer. Aliquots of the fractions corresponding to 35 pg of 
untreated mitochondria were immediately assayed for pro- 
cessing activity and the rest of the samples was stored at - 
20°C. 
Synthesis of precursor proteins 
Cell-free synthesis of Neurospora precursor proteins in 
rabbit reticulocyte lysates was carried out as before [I 31. Post- 
ribosomal supernatants of lysates were desalted by centrifug- 
ing through Sephadex G-25 equilibrated with 30 mM Tris/ 
HCl, pH 8.2 and stored in aliquots of 100 p1 at -75°C. 
For sequencing experiments the precursor to Su 9 was 
synthesized in vitro in a total volume of 20-60 pl of trans- 
lation mixture (reticulocyte lysates, Amersham Buchler, 
Braunschweig, FRG) in the presence of 1.2 mCi/ml 
[35S]methionine (1250 Ci/mmol, Amersham) or 1 mCi/ml 
[3HJleucine (110 Ci/mmol, NEN Chem., Boston, MA, USA). 
The lysates were programmed with hybridization-selected 
mRNA specific for Su 9 [14]. 
Transfer in vivo of subunit 9 
Neurosporu cells were grown for 14 h as described above. 
An aliquot of the culture containing 30mg of cells was re- 
moved and cooled to 8°C. Cells were labeled with 5 pCi/ml 
[3H]leucine (50 Ci/mmol, NEN Chem., Boston, MA) for 3 min, 
and the assay was divided into three portions. The first portion 
was immediately precipitated by adding trichloroacetic acid 
to a final concentration of 0.3 M. The remaining two portions 
were subjected to another incubation for 3 min at 8°C in 
the presence of 0.1 mg/ml cycloheximide or cycloheximide 
and EDTA,’I ,lo-phenanthroline ( 5  mM/1 mM, respectively). 
Then these portions were also precipitated with trichloroacetic 
acid. The samples were kept at 0°C for 30 min, washed with 
5 ml of acetone and dissolved in 1 ml of 1% (w/v) sodium 
dodecylsulfate, 50 mM Nap,, pH 8.0 by boiling for 5 min. 
After dilution with Triton containing buffer (IYo w/v Triton 
X-100, 0.3 M NaCl, 5 mM EDTA, 10 mM Tris/HCl, pH 7.5) 
the samples were immunoprecipitated for Su 9 as described 
previously [ 1 11. 
Isolation of proteins and immunoprecipitation 
Cytosolic proteinase inhibitor fraction was prepared 
according to the following protocol: 150 g of freshly harvested 
Neurospora cells were washed in 6 1 of ice-cold water. Cells 
were homogenized in a Waring blendor after adding 450 ml 
of water. The slurry was made 5% (v/v) in perchlorid acid 
and incubated for 10 min at 65°C. After cooling to room 
temperature, 5 M KOH was added until neutral pH was re- 
ached. The mixture was centrifuged for 10 min at 12000 x g. 
The supernatant was subjected to fractionation by ammonium 
sulphate precipitation. Material that precipitated between 
25% and 75% saturation was collected and dissolved in water. 
After a clarifying spin (20 min at 29 000 x g) the solution was 
vigorously shaken for 5 min with an equal volume of 
chloroform. The aqueous phase was recovered by centrifuga- 
tion and lyophilized. The dried material was redissolved in 
10 ml of water and subjected to gel filtration on a Sephadex 
G-25 column (25 x 350 mm) equilibrated with water. The flow 
rate was 120ml/h. Turbid fractions appearing in the void 
volume were pooled, lyophilized and redissolved in water at 
a protein concentration of 3 mg/ml and stored at -20°C. The 
yield was 250 pg/g of hyphae. This fraction was able to inhibit 
mitochondria associated proteolytic activity measured with 
azocoll as a substrate by 90% at a ratio of 140 pg/mg 
mitochondrial protein. 
Isolation of proteins, preparations of antibodies and im- 
munoprecipitation of Su 9 [II ,  151, F,ATPase subunit p [16], 
Fe-S protein [5], cytochrome c1 [5], porin [17], and citrate 
synthase [I 81 were performed as described earlier. 
Determination of enzymatic activities 
Fumarase and succinate-cytochrome-c-reductase activi- 
ties were determined according to [19, 201. Adenylate kinase 
was assayed in a mixture composed of 1 ml of 130 mM KC1, 
6 mM MgS04, 100 mM Tris/HCI, pH 7.5, 20 p1 of 0.1 M 
NADH, 5 p1 of 0.1 M ATP, 10 p1 of 50 mM phosphoenol 
pyruvate, 5 p1 of 1 mM rotenone, 5 p1 of 1.5 mM oligomycin, 
10 p1 of a mixture of pyruvate kinase and lactate dehydro- 
genase (20 U/ml each), 200 pl of the sample. The reaction 
was started by adding 5 pl of 0.15 M AMP and followed 
by the decrease of absorbance at 366 nm. The samples for 
fumarase and adenylate kinase assays were adjusted to 2.5% 
(w/v) Genapol X-100 (Hoechst AG, Frankfurt, FRG) im- 
mediately before starting the reaction. The processing activity 
was determined as fOllOW!j: 100 pl of desalted reticulocyte 
lysate containing radiolabeled precursor proteins were mixed 
with 100-400 PI containing the sample to be assayed and 
30 mM Tris/HCl, pH 8.2. Then 10 pl of 10% (w/v) Triton X- 
100, I pl of 0.1 M phenylmethylsulfonyl fluoride (in ethanol) 
and 2 p1 of 0.1 M MnClz were added per 100 p1 of assay 
volume. The mixture was incubated for 1 h at 25°C. The 
reaction was stopped by adding 10 pl of 3 M NaCI, 50 mM 
EDTA, pH 8.2 per 100 p1 of volume. The processing products 
were analyzed by immunoprecipitation, dodecylsulfate 
polyacrylamide electrophoresis and fluorography (see below). 
Analytical procedures 
Protein was determined according to Bradford [21]. 
Electrophoresis in 16% polyacrylamide gels was carried out 
according to Laemmli [22], Fluorography and densitometry 
of films were performed as previously [23, 241. Isolation of 
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proteins for Edman degradation was carried out by im- 
munoprecipitation and subsequent electrophoresis. After 
fluorography the bands of interest were cut out, washed in 
water and extracted with 600 pl of 1 % (w/v) SDS, 30 mM 
Napi, pH 8.2 at 57°C overnight. The eluted material was 
subjected to automated solid phase Edman degradation [25]. 
Immunoreplica analysis using lactoperoxidase linked to sheep 
anti-rabbit-antibodies was performed as described in [26]. 
RESULTS 
Processing peptidase cleaves the precursor 
to ATPase subunit 9 in two steps 
Radiolabeled reticulocyte lysates containing pre Su 9 were 
incubated with a fixed amount of an extract prepared from 
Neurospora mitochondria. The processing products were 
analyzed by immunoprecipitating the samples with antibodies 
against Su 9. The time course of processing over a period of 
1.5 h is shown in Fig. 1 A. The appearance of mature-sized 
Su 9 (Fig. l A ,  lane 10) is preceeded by the formation of a 
band which has an M ,  of 13000. This intermediate was also 
observed, when intact Neurospora mitochondria were incubat- 
ed with radiolabeled reticulocyte lysates in the presence of 
chelating agents to inhibit processing peptidase [16]. The pro- 
cessing activity observed in this experiment is clearly contrib- 
uted by the mitochondrial extract, because upon incubation 
without extract there was no detectable processing (Fig. 1 A, 
lane 9). As mentioned earlier [l 11, the antibody against Su 9 
does not precipitate the precursor very efficiently, apparently 
because the large additional sequence consisting of 66 
essentially hydrophilic amino acids [14] shields or alters anti- 
body binding sites on the 81 amino acid sequence correspond- 
ing to the mature protein. The time course shown in Fig. 1 A 
was quantified by densitometry of exposed films (Fig. 1 B) 
and compared to a dose-response curve that was processed 
in the same way (Fig. 1 C). The last point in the dose-response 
curve showed a band pattern comparable to that of lane 5 in 
Fig. 1 A. Both curves gave essentially a linear response up to 
a point where approximately equal amounts of intermediate- 
sized and mature-sized Su 9 were produced. So it is possible 
to regard them a standard curves of enzymatic activity to 
which any given activity can be compared and quantified 
irrespective of whether one calculates the ratio mji (m = 
amount of mature Su 9, i = amount of intermediate) or the 
sum of processing products m + i. 
Processing peptidase activity depends on the presence of Mn2+ 
Processing activities in extracts of mitochondria were 
shown to depend on the presence of divalent metal ions such 
as  Zn2+ or Mn2+ [7, 81. This is also true for Neurospora 
processing peptidase (Fig. 2, lane 2 versus lane 3). According- 
ly, processing peptidase is inhibited by chelating agents such 
as phenanthrolines and EDTA (Fig. 2, lanes 4 - 6). This exper- 
iment also shows that not only the first step is metal dependent 
(Fig. 2, lanes 4, 6), but also the second step (Fig. 2, lane 2). If 
the second step does not require metal ions, one would except 
to see only mature Su 9 in Fig. 2, lane 2. The Mn2+-concentra- 
tion in this sample was suboptimal. 
The inhibition of processing peptidase by chelating agents 
was also observed in vivo. Neurospora cells were pulse labeled 
with [3H]leucine and subjected to a chase period in the pres- 
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Fig. 1. Processing of the precursor to subunit 9 by a mitochondrial 
extract. (A) Aliquots of desalted lysate (100 pl each) containing 
radiolabeled precursors were incubated as described in Materials and 
Methods in a final volume of 225 pl with 20 pl of a mitochondrial 
extract for various time periods. Su 9 was immunoprecipitated and 
subjected to electrophoresis. Bands were visualized by fluorography. 
Lane 9 contained no mitochondrial extract. Mature Su 9 (lane 10) was 
immunoprecipitated from mitochondria labeled in vitro. p, precursor; 
i, intermediate; m, mature Su 9 (B). The time course of processing 
shown in A was quantified by densitometry of exposed films. The 
values of m + i and m/i are plotted versus the time of incubation. 
(C) Aliquots of desalted lysate (100 pl each) were incubated as in A 
with the indicated amounts of mitochondrial extract for 1 h. Su 9 was 
immunoprecipitated and subjected to electrophoresis. Bands were 
quantified by densitometry of exposed films. The values of m + i and 
m/i are plotted versus the volume of mitochondrial extract 
ence and absence of EDTA and 1,lO-phenanthroline. As 
shown in Fig. 3,  the chelating agents inhibited the production 
of mature Su 9 and conserved the band pattern obtained 
during the pulse showing precursor, intermediate, and mature 
Su 9. The conditions employed were not such as to inhibit 
transport of proteins into mitochondria. Transport of ADP/ 
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Fig. 2. Processing peptidase is inhibited by chelating agents. Aliquots 
of desalted lysate containing radiolabeled precursors (100 p1 each) 
were incubated with 20 pl of mitochondrial extract in a final volume 
of 225 p1 for 1 h. Reactions contained: lanes 2, 3, no additions; 
lane 4, 2 mM 1,lO phenanthroline; lane 5 ,  2 mM bathophenanthro- 
line disulfonic acid; lane 6, 2 mM EDTA. In lane 2, MnZ+,  usually 
present in the processing assay at a concentration of 2 m M  (see 
Materials and Methods), was omitted. Lane 1 shows precursor im- 
munoprecipitated from untreated lysate. Su 9 was immunoprecipitat- 
ed and subjected to electrophoresis. Bands were visualized by fluoro- 
graphy. p, precursor; i, intermediate; m, mature Su 9 
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Fig. 3. Processing in vivo ofsubunit 9 is inhibited by chelating agents. 
30 mg of Neurospora cells (wet weight, 10 ml of culture) were pulse 
labeled with 50 pCi of [3H]leucine for 3 min at 8'C. The culture was 
divided into three portions. The first one was immediately precipitated 
with trichloroacetic acid (final concentration 0.3 M) (lane 1). The 
remaining two portions were further incubated for 3 min at 8°C in 
the presence of 0.1 mg/ml cycloheximide (lanes 2, 3) and 5 mM 
EDTAjl mM 1,lO-phenanthroline (lane 3 only). Then these protions 
were precipitated with trichloroacetic acid. After solubilization of 
proteins, Su 9 was immunoprecipitated and subjected to electro- 
phoresis. Bands were visualized by fluorography. p, precursor; i, 
intermediate; m, mature Su 9 
ATP carrier, a protein whose precursor has no cleavable pep- 
tide extension [27] was not inhibited (data not shown), which 
indicates that transfer of proteins into mitochondria is not 
unspecifically affected. This result further suggests that inter- 
mediate sized Su 9 is not an in vitro artifact. 
Processing peptidase could not be inhibited by N-ethyl- 
maleimide, p-hydroxymercuribenzoate, benzamidine, phen- 
ylmethylsulfonyl fluoride, I-tosylamido-2-phenylethyl chlo- 
romethyl ketone (TPCK), N-tosyl-lysine chloromethyl 
ketone (TLCK), aprotinin, bestatin or EGTA (data not 
shown). This is in agreement with the behaviour of 
mitochondrial processing enzymes described by others [8, 101. 
Another characteristic of the peptidase is that the activity in 
this assay is stimulated about three fold by Triton X-100 at a 
concentration of 1% (w/v) (data not shown). An explanation 
for this observation might be that the detergent mimics a 
membranous environment for the precursor thus facilitating 
the action of processing peptidase. It was suggested previously 
[16] that pre S u 9  embedded in the inner membrane of 
mitochondria is the substrate for processing peptidase in in- 
tact mitochondria. 
U 
Q, 
UI 
Succ-Cyt c -  Red " 
1 2 3 4  
Digitonin concentration (rnglml) 
Fig. 4. Localization ofprocessing peptidase. Mitochondria were treat- 
ed with digitonin as described in Materials and Methods and recovered 
by centrifugation. Aliquots of the resuspended mitochondria and 
the respective supernatants corresponding to 35 pg of untreated 
mitochondria were assayed for processing activity in the presence of 
Triton X-100. The assay was carried out in a final volume of 600 pl 
for 1 h employing 100 pl of desalted lysate containing radiolabeled 
precursors. Su 9 was immunoprecipitated and the precipitates were 
analyzed by electrophoresis. Bands were visualized by fluorography 
and quantified by densitometry of exposed films. Processing peptidase 
activity was determined by calculating the sum of intermediate and 
mature forms of Su 9. Marker enzymes were assayed as described 
in Materials and Methods. For each digitonin concentration, the 
activities recovered from mitochondrial pellets and supernatants were 
set to 100%. The percentage of enzyme activity released from 
mitochondria is plotted versus the amount of digitonin used. 
( x ~ x ) Adenylate kinase (Adk); (0- ~ - -0) fumarase; 
(0-0) processing peptidasc (Proc. Pept.); ( x ~ x ) succinate- 
cytochrome-c-reductase (Succ-Cyt c-Red) 
Processing peptidase is a matrix-located activity 
In order to determine the submitochondrial location of 
processing peptidase and especially to answer the question, 
whether both processing steps occur in the same subcompart- 
ment of mitochondria, we developed a fractionation proce- 
dure for small amounts of Neurospora mitochondria. Based 
on a protocol published prcviously [28], we used increasing 
concentrations of digitonin to differentially solubilize outer 
and inner membrane under conditions that preserved process- 
ing peptidase activity. This was only possible by employing a 
cytosolic protease inhibitor fraction from Neurospora (see 
Materials and Methods). The procedure allowed us to separ- 
ate intermembrane space, matrix and inner membrane from 
each other as judged by the separation of marker enzyme 
activities. These enzymes were adenylate kinase, fumarase, 
and succinate-cytochrome c-reductase, respectively. In Fig. 4, 
the release of enzyme activity from the mitochondria is plotted 
versus the amount of digitonin used. Processing peptidase 
activity was estimated by calculating the sum of processing 
products [m + i, see above) after densitometry of exposed 
films. The band pattern obtained with the fraction containing 
the highest activity was essentially the same as that of Fig. 1 A, 
lane 5. Processing peptidase fractionated with the matrix 
marker fumarase. 
To exclude the possibility that processing peptidase is as- 
sociated with the outer membrane whose distribution was 
not followed in the experiment of Fig. 4, mitochondria were 
fractionated into membraneis and soluble material in the pres- 
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Fig. 5. Processing peptidase is water-soluble. Mitochondria were 
sonicated and centrifuged to separate membranes from the water- 
soluble fraction. The distribution of the matrix marker citrate 
synthase (A) and the outer membrane marker porin (B) was monitored 
by immunoreplica analysis. Lanes 1 - 3, 10, 5,2.5 pg, respectively, of 
untreated mitochondria; lane 4, the supernatant fraction, correspond- 
ing to 10 pg of untreated mitochondria; lane 5 ,  membrane fraction, 
corresponding to 10 pg of untreated mitochondria. (C) The fractions 
were assayed for processing peptidase activity in aliquots of desalted 
lysate containing radiolabeled precursors (100 pl each) in a final 
volume of 225 pl for 1 h. Su 9 was immunoprecipitated and subjected 
to electrophoresis. Bands were visualized by fluorography. Lanes 1 - 
3, 25, 12.5, 6.25 pg, respectively, of untreated mitochondria; lane 4, 
supernatant fraction, corresponding to 25 pg of untreated mito- 
chondria; lane 5, membrane fraction, corresponding to 26 pg of 
untreated mitochondria. p, precursor; i, intermediate; m, mature 
s u  9 
ence of cytosolic protease inhibitor fraction (Fig. 5). The 
distribution of the matrix marker citrate synthase and the 
outer membrane marker porin [17] was monitored by Western 
blotting. Again, processing peptidase fractionated with the 
matrix marker. 
The coincidence of the matrix marker enzymes and the 
processing activity strongly suggests that processing peptidase 
is a water-soluble activity located in the mitochondrial matrix. 
Processing peptidase acts differently 
on various precursor proteins 
The processing of precursor proteins others than pre 
Su 9 was investigated in the standard processing asssay. 
Radiolabeled reticulocyte lysates were incubated with 
mitochondrial extract for 1 h. The samples were im- 
munoprecipitated for F1-ATPase subunit p (FIB), cytochrome 
cl, and the Fe-S protein of the bcl-complex (ubiquinol- 
cytochrome c-reductase) (Fig. 6). The precursor to FIP was 
processed to the mature-sized polypeptide. The precursor to 
cytochrome c1 was processed to an intermediate-sized band. 
This intermediate was observed in intact cells and in whole 
mitochondria in vitro [5].  Further processing has been shown 
to require the covalent addition of a heme group and the 
action of a protease different from the metal-dependent matrix 
protease [6]. The precursor to the Fe-S protein was not pro- 
cessed by processing peptidase extracted from mitochondria. 
The reason for this is not known. One possibility is that this 
precursor is easily denatured under the conditions used, so 
that is no longer a substrate for processing peptidase. It is 
equally possible that a prerequisite for the proteolytic process- 
ing is the addition of Fe which might not work in our system, 
or that a specific membrane precursor orientation is required 
which is not available in our assay system. 
Fe/S Protein 
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Fig. 6. Processing of various mitochondrialprecursor proteins. Aliquots of desalted lysate containing radiolabeled precursors (100 p1 each) were 
incubated with 20 p1 of mitochondrial extract for 1 h in a final volume of 225 pl. The samples were immunoprecipitated for ATPase subunit 
b, cytochrome c1 and the Fe/S protein. The precursors were immunoprecipitated from untreated lysates and the respective mature proteins 
from mitochondria labeled in vivo. After electrophoresis, the bands were visualized by fluorography. Lanes 1 - 3, ATPase subunit b, lanes 
4-6, cytochrome c l ;  lanes 7-9, Fe/S protein; lanes 1, 4, 7, precursors; lanes 2, 5 ,  8 processing products; lanes 3, 6, 9, mature proteins; p, 
precursor; i. intermediate; m, mature 
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Fig. I .  Sequence analysis of intermediate and mature-sized subunit 9 
processedin vitro. (A) The precursor to Su 9 was synthesized in a final 
volume of 20 p1 of reticulocyte Iysate programmed with hybridization 
selected mRNA in the presence of [35S]methionine. The postribo- 
soma1 supernatant was incubated for 1 h with a soluble fraction 
derived from 525 pg of digitonin-treated mitochondria under the 
same conditions as described in Materials and Methods. The final 
volume was 250 p1. Su 9 was immunoprecipitated and subjected to 
electrophoresis. Bands were visualized by fluorography. Mature-sized 
Su 9 was eluted from the gel (32400 cpm) and analyzed by solid-phase 
Edman degradation (B). Upper panel: intermediate sized Su 9 was 
eluted from the same gel as in A (12000 cmp) and analyzed as in A. 
Lower panel: the precursor to Su 9 was synthesized in a final volume 
of 50 pl of reticulocyte lysate as in A in the presence of [3H]leucine. 
The postribosomal supernatant was incubated for 30 min at 0°C with 
antibodies to Su 9. Processing was carried out as in A with a fraction 
corresponding to 360 pg of mitochondria in a volume of 200 pl. 
Analysis of intermediate sized Su 9 (1 5 000 cpm) was performed as in 
A. Amino acid sequences of pre Su 9 are denoted in the one letter 
code 
Table 1 .  Comparison of the cleavage sites 
The amino acid sequences around the cleavage sites in the precursor 
to Su 9 (A. first cleavage site; B, second cleavage site) are denoted in 
the three letter code. The sequences given start with (A) alanine-38 
and (B) glutamine-7. (C) The amino acid sequence around a putative 
cleavage site in the precursor to yeast cytochrome c peroxidase [29] 
starting with arginine-56 is presented. The cleavage sites are indicated 
by an arrow 
A Ala -Gln-Val -Ser -Lys -Arg-Thr-Ile -Gln-Thr-Gly 
B Gln -Ala -Phe-Gln-Lys -Arg-Ala -Thr-Ser -Ser -Glu 
C Arg-Thr-Ala-His -Lys-Arg-Ser -Leu-Tyr -Leu-Phe 
Processing peptidase cleaves the precursor 
to ATPase subunit 9 at the correct site 
Molecular cloning made possible the determination of the 
amino acid sequence of pre Su 9 [14]. To determine the 
cleavage sites of processing peptidase in the pre Su 9 molecule, 
we carried out sequencing experiments with mature-sized and 
intermediate-sized Su 9. The precursor was synthesized in 
reticulocyte lysates programmed with hybridization-selected 
mRNA [I41 in the presence of labeled methionine. After pro- 
cessing with a matrix fraction obtained from digitonin-treated 
mitochondria, the processing products were immuno- 
precipitated, and subjected to electrophoresis. Mature and 
intermediate forms of Su 0 were eluted from the gel and 
subjected to automated solid phase Edman degradation. 
Fig. 7A shows the result of the sequencing of the mature- 
sized protein. There are two methionine peaks at position 9 
and 18 as in the mature protein and an additional peak at 
position 14 coming from a lysine residue. Su 9 is coupled via 
lysine residues to the solid phase, so each lysine must also give 
a signal [25].  This result clearly indicates that the correct 
amino terminus is produced by processing peptidase. When 
the intermediate was sequenced, one lysine and one methio- 
nine peak was observed in the 11 th and 15th cycle, respective- 
ly. In this experiment, extensive washing of the solid phase 
after binding of intermediate Su 9 was omitted. Thus, 
unspecifically absorbed material was eluted during the first 
Edman step resulting in a peak that does not tail. There is 
only one possibility that this pattern fits into the sequence of 
pre Su 9: the NH,-terminus of the intermediate is isoleucine 
in position -31 (Fig. 7B, upper part). To confirm this inter- 
pretation, leucine-labeled intermediate was sequenced 
(Fig. 7B, lower part). This intermediate was obtained by 
carrying out the processing assay with precursor that had been 
incubated with antibodies to Su 9. Under these conditions the 
precursor was quantitatively processed only to the intermedi- 
ate, and no mature Su 9 was observed (data not shown). Two 
leucine peaks were detected in the 7th and 10th cycle. The 
sequence -Leu-Xaa-Xaa-Leu- occurs only once in the whole 
precursor molecule between the positions leucine-25 and 
leucine-21. This again strongly suggests that isoleucine-31 is 
the NH2-terminal amino acid of the intermediate. 
Table 1 summarizes these results. The amino acid se- 
quences around the cleavage sites of pre Su 9 are presented. 
They show striking similarities in that they appear to follow 
the rule (concerning the properties of amino acids): 
hydrophobic-polar-Lys-Arg-small- - - - -bulky hydrophobic. 
Such a sequence is also found in the precursor to yeast 
cytochrome c peroxidase [29] that seems to indicate a putative 
first cleavage site. It was suggested [6] that this precursor is 
cleaved in two steps during its assembly, the first step being 
catalyzed by the matrix protease. It should be mentioned, 
however, that the cleavage site in this protein has not been 
determined. Despite the remarkable homology between these 
sequences, it is not known whether they represent recognition 
sites for processing peptidase. 
DISCUSSION 
The processing peptidase present in extracts of mito- 
chondria cleaves the precursor to ATPase subunit 9 in a specif- 
ic manner, so that the correct NH2-terminus of the mature 
protein is produced. Processing peptidase is a metal-depen- 
dent enzyme located in the mitochondria1 matrix. Proteolytic 
processing activities from different sources have been 
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described [7 - 10, 30, 311. These activities show a high degree 
of homology in function and properties when compared to 
Neurospora processing peptidase. Processing peptidase 
appears to be responsible for the cleavage of a number of 
precursor proteins that are destined for different submito- 
chondrial compartments. It is not known, however, how many 
different peptidases in the matrix of mitochondria are required 
for the processing of the probably several hundred different 
precursor proteins. Interestingly, yeast mitochondria contain 
a processing activity that cleaves Neurospora pre Su 9 correctly 
[15], although the homologous protein in yeast is made inside 
the mitochondria [32]. This implies that there may be only a 
limited number of processing peptidases or even only one such 
enzyme. This would be similar to the situation with secreted 
proteins in the endoplasmic reticulum and in bacteria [33, 341. 
The matrix location of processing peptidase implies that 
pre Su 9 has to cross the inner mitochondrial membrane 
partially during its assembly to expose the NHz-terminal extra 
sequence to the matrix. The rest of the precursor molecule 
appears to be firmly bound to the inner membrane [16]. There 
is some evidence that the NH,-terminus of mature Su 9 faces 
the intermembrane space [35]. This would mean that the 
NHz-terminus has to be translocated back across the inner 
membrane after the second processing. 
The mitochondria-free system used in this work produced 
a kinetic intermediate during processing of pre Su 9. A two- 
step processing of pre Su 9 was expected since precursor 
transfer experiments in vitro with intact mitochondria have 
revealed an intermediate when processing was slowed down 
in the presence of chelating agents [16]. In the absence of 
such chelators the intermediate has not been observed [ll]. 
Probably under normal conditions the rate-limiting step is the 
first cleavage. The in vivo processing experiments presented in 
this paper indicate that intermediate sized Su 9 is not an in vitro 
artifact, but represents a true intermediate in the assembly 
pathway of Su 9. No additional processing steps between 
precursor and intermediate and between intermediate and 
mature Su 9 have been observed. However, additional 
cleavages cannot be ruled out a priori. Indeed, there is a 
sequence between intermediate and mature forms which is 
rather similar to the two established cleavage sites (around 
threonine-I 9 and glutamine-1 8). The physiological meaning 
for the two-step processing is not known. It is remarkable, 
however, that the additional sequence of pre Su 9 is 
exceptionally large. 
The two cleavage sites in the pre Su 9 molecule are homolo- 
gous to each other as judged from the similarities in primary 
structure. This type of structure is also found in the precursor 
to yeast cytochrome c peroxidase (see Table 1). This sequence 
may be the site of cleavage leading to the formation of an 
intermediate in cytochrome c peroxidase assembly. There are, 
however, no structural data available to substantiate this pro- 
posal. As only a few sequences of mitochondrial precursor 
proteins are available, it is difficult to tell what characteritic 
of this type of sequence is the minimal requirement for the 
recognition of these sites by mitochondrial processing 
peptidase. The precursor of yeast mitochondrial EF-Tu [36] 
does not contain such a sequence and the question remains 
to be answered, whether this precursor is processed by the 
same enzyme that cleaves the precursor to yeast cytochrome 
c peroxidase. 
There are several lines of evidence that pre Su 9 is cleaved 
in two steps by the same enzyme: (a) both processing steps 
take place in the same subcompartment of mitochondria, 
i.e. the matrix; (b) both steps show the same sensitivity to 
inhibitors; (c) the cleavage sites are very similar to each other. 
Other precursor proteins that are cleaved in two steps appear 
to require two different proteolytic processing enzymes from 
probably different submitochondrial locations. This has been 
shown for cytochrome c1 [5 ,  61 in Neurospora and yeast and 
for cytochrome bz [6, 101 in yeast. It is also probably true 
for yeast cytochrome c peroxidase [6]. The submitochondrial 
location of the second processing enzyme is not clear, because 
an assay in a mitochondria-free system is not yet available. 
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